Recombinant
Health Care Term
In the healthcare industry, recombinant DNA technology has become an essential part of modern medicine. It has revolutionized the way drugs are produced, leading to the development of novel treatments for a wide range of diseases. For example, the production of insulin for the treatment of diabetes involves the use of recombinant DNA technology. The human insulin gene is inserted into a bacterium, which then produces large quantities of insulin. This recombinant insulin is then purified and used as a therapeutic product.
Recombinant protein technology has also been used to develop a variety of therapeutic antibodies, hormones, and growth factors that are used in the treatment of many medical conditions such as cancer, autoimmune diseases, and genetic disorders. Additionally, recombinant DNA technology has been used to develop vaccines against a number of infectious diseases, including hepatitis B, human papillomavirus (HPV), and influenza.
Overall, recombinant DNA technology has been a game-changer in the healthcare industry, enabling the development of new treatments that were previously unimaginable. It has opened up new possibilities for treating and preventing many disorders, leading to significant improvements in human health.
More Glossary Terms Beginning with R
-
Radiolabeling
Health Care Term Letter: R
-
Radiopharmaceutical
Health Care Term Letter: R
-
Randomized Clinical Trial
Health Care Term Letter: R
-
Rate of Change ROC
Technical Indicator Letter: R
-
Rating Agency Condition
Financial Term Letter: R
-
Reagent
Health Care Term Letter: R
-
Receivables From Customers
Financial Term Letter: R
-
Receivables Turnover Ratio
Fundamental Analysis Letter: R
-
Receptor
Health Care Term Letter: R
-
Recession
Economy Term Letter: R
-
RECIST
Health Care Term Letter: R
-
Recombinant
Health Care Term Letter: R
